Effect of enzyme replacement therapy (ERT) on lung involvement and changes of different peripheral blood T-cell subsets in Fabry disease patients

B. Odler, T. Constantin, G. Fekete, G. Losonczy, A. Cseh, L. Tamasi, V. Muller (Budapest, Hungary)

Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Session: Clinical management of orphan lung diseases
Session type: Oral Presentation
Number: 1795
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Odler, T. Constantin, G. Fekete, G. Losonczy, A. Cseh, L. Tamasi, V. Muller (Budapest, Hungary). Effect of enzyme replacement therapy (ERT) on lung involvement and changes of different peripheral blood T-cell subsets in Fabry disease patients. Eur Respir J 2013; 42: Suppl. 57, 1795

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of long-term oxygen therapy on systemic inflammation, morphological changes of red blood cells, pulmonary hemodynamics and diaphragm function in patients with chronic obstructive pulmonary disease.
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018


Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy
Source: Eur Respir J, 59 (3) 2101798; 10.1183/13993003.01798-2021
Year: 2022



Effects of smoking on lymphocyte subsets of peripheral blood in patients with chronic renal failure
Source: Annual Congress 2008 - The biology of smoking and COPD
Year: 2008


Metabolic changes in peripheral blood mononuclear cells (PBMCs) of subjects with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017


Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017


Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

Significant changes in monocyte subsets during infliximab therapy in severe sarcoidosis
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015


Characteristics of glucose metabolism in patients receiving glucocorticoid therapy for interstitial lung disease.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017

Changes in the populations of blood T-lymphocytes containing chemokine receptors in non-smoking patients with COPD
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013


Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003

Respiratory function in systemic sclerosis patients
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015


Regulatory T-lymphocytes in peripheral blood of never smoking patients with COPD
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013


Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019




Systemic inflammation, blood eosinophils count and lung function in COPD patients
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017


Analysis of peripheral blood lymphocytes in asthma and chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010

The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


Diminished peripheral T cell activity in sarcoidosis associates with progressive disease.
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018



Determinants of peripheral blood neutrophils in advanced chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010